Sign inJoin waitlistJoin the waitlist

Paul Spearman

Vice Chair · Cincinnati Children's Hospital Medical Center

Credentials: · · · · ·

History

Cincinnati Children's Hospital Medical Center
Present
SPS Advisor Program · University of Cincinnati Medical Center Inc.
Present
University of Cincinnati Medical Center Inc.
Present

Infectious Disease
Washington University/B-JH/SLCH Consortium
1991–1993
Ohio State University College of Medicine
1986–1990
Univ of Texas Southwestern Med Sch at Dallas
1982–1986

Research

Neonatal infectious diseases: evaluation of neonatal sepsis
Review · Pediatric Clinics of North America · 2013 · 288 citations
Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions
Journal of Virology · 1993 · 272 citations
Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly
Journal of Virology · 1994 · First of 4 authors · 237 citations

Juliana McElrath
12 papers
Sharon Frey
9 papers
James Crowe
8 papers
Lee Ratner
8 papers
MM
Mark Mulligan
8 papers
Paul Goepfert
8 papers
Spyros Kalams
8 papers
EA
Evan Anderson
7 papers
NR
Nadine Rouphael
7 papers
XW
Xiaoyun Wen
7 papers
Lawrence Corey
6 papers
Michael Keefer
6 papers

Grants

Viral and Cellular Determinants of HIV-1 Assembly
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.8M · Cincinnati Childrens Hosp Med Ctr
2024–2029
Role of CLIC/GEEC Pathway in VCC Formation and HIV-1 Transmission from Macrophages
National Institute of Allergy and Infectious Diseases · R56
Contact PI · $703.4K · Cincinnati Childrens Hosp Med Ctr
2026–2027
Modeling HIV and Methamphetamine-Induced Neuroinflammation in Cerebral Organoids
National Institute on Drug Abuse · R01
Contact PI · $3M · Cincinnati Childrens Hosp Med Ctr
2022–2027
Vaccinology Training Program
National Institute of Allergy and Infectious Diseases · T32
Contact PI · $1.4M · Cincinnati Childrens Hosp Med Ctr
2022–2027

Clinical trials

Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults
Principal investigator · Completed · Phase 1
Blue Lake Biotechnology Inc.
2022–2023
Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents
Principal investigator · Completed · Phase 1
CyanVac LLC
2021–2023
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2011–2014
Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2004–2006